Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: sleep

Orexin’s Yin/Yang Functions Regulate Bone Remodeling

Lara C. Pullen, PhD  |  July 3, 2014

Working both to support bone formation and suppress it, a new study reveals orexin neuropeptides are essential regulators of skeletal homeostasis

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:bone formationbone remodelingOsteoporosisResearch

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2014

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ActemrabaricitinibbelimumabBiologicsdrugLupusResearchRheumatoid arthritisSafetySystemic lupus erythematosustocilizumabzoledronic acid

How to Manage Physician Burnout

Vanessa Caceres  |  July 1, 2014

Stress-coping techniques for physicians under strain of healthcare industry changes

Filed under:EMRsPractice SupportTechnologyWorkforce Tagged with:ACAAffordable Care Act (ACA)burnoutelectronic health recordphysicianPractice Managementrheumatologiststress managementTechnology

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

Atul Deodhar, MD  |  May 1, 2014

New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

Filed under:Axial SpondyloarthritisConditionsResearch Rheum Tagged with:Ankylosing Spondylitisanti-inflammatoryaxial skeletal inflammationaxial spondyloarthritis (SpA)DrugsepidemiologyimagingPainpatient careradiographResearchrheumatologistrituximabterminologyTofacitinib

Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

Susan Bernstein  |  April 2, 2014

Observational pain scales, diagnostic tools, pharmacologic interventions, and support from psychologists, caregivers recommended

Filed under:ConditionsMeeting ReportsPain SyndromesRheumatoid Arthritis Tagged with:ACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)DepressiondrugFibromyalgiaPainpatient carepsychological disorderRheumatic DiseaseRheumatoid arthritisrheumatologist

Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine

Filed under:ConditionsDrug UpdatesMeeting ReportsOsteoarthritis and Bone DisordersOther Rheumatic ConditionsRheumatoid Arthritis Tagged with:ACR/ARHPAdenosineanti-inflammatorybonedrugMethotrexateOsteoarthritispatient careRheumatoid arthritisrheumatologist

Mobile Health Devices May Have Limited Use in Rheumatology

Simon M. Helfgott, MD  |  April 2, 2014

Challenges exist in developing m-health apps for rheumatology patients because of the difficulty in pinpointing what needs to be measured

Filed under:AppsOpinionPractice SupportQuality Assurance/ImprovementRheuminationsSpeak Out RheumTechnologyTechnology Tagged with:appsHelfgottpatient carePractice ManagementrheumatologistTechnology

Exploring Kawasaki Disease

Mary Beth Son, MD  |  April 2, 2014

New epidemiologic data, clinical studies have shed light on diagnosis, treatments, patient outcomes for this childhood disease, but etiology is still unknown

Filed under:Clinical Criteria/GuidelinesConditions Tagged with:ACR/ARHP Annual Meetingimmune intravenous globulininfliximabJuvenile idiopathic arthritisKawasaki diseasepatient carerheumatologist

What Role Does Fascia Play in Rheumatic Diseases?

Helene M. Langevin, MD  |  March 1, 2014

Recent research explores possible connections between abnormalities in fasciae and painful musculoskeletal conditions such as chronic back pain, osteoarthritis, and rheumatoid arthritis, as well as scleroderma

Filed under:ConditionsOsteoarthritis and Bone DisordersPain SyndromesResearch RheumRheumatoid ArthritisSystemic Sclerosis Tagged with:anti-inflammatoryFibromyalgiaOsteoarthritisPainpatient careResearchRheumatic DiseaseRheumatoid arthritisrheumatologistScleroderma

Rheuminations: Rheumatologists Seek Better Understanding of Fibrosing Disorders

Simon M. Helfgott, MD  |  December 1, 2013

Research into scleroderma, fibrosis, and Raynaud’s phenomenon may provide clues into the pathogenesis of systemic sclerosis

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:fibrosisPathogenesisRaynaud’s phenomenonSclerodermaSystemic sclerosis

  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 36
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences